Massimo Cristofanilli

Massimo Cristofanilli

UNVERIFIED PROFILE

Are you Massimo Cristofanilli?   Register this Author

Register author
Massimo Cristofanilli

Massimo Cristofanilli

Publications by authors named "Massimo Cristofanilli"

Are you Massimo Cristofanilli?   Register this Author

100Publications

3136Reads

50Profile Views

Comparing the Performances of Magnetic Resonance Imaging Size vs Pharmacokinetic Parameters to Predict Response to Neoadjuvant Chemotherapy and Survival in Patients With Breast Cancer.

Curr Probl Diagn Radiol 2019 May - Jun;48(3):235-240. Epub 2018 Mar 28.

Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1067/j.cpradiol.2018.03.003DOI Listing
August 2019

Elevated serum levels of sialyl Lewis X (sLe) and inflammatory mediators in patients with breast cancer.

Breast Cancer Res Treat 2019 Aug 3;176(3):545-556. Epub 2019 May 3.

Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1220 Holcombe Blvd, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05258-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653624PMC
August 2019

Recent advances with cyclin-dependent kinase inhibitors: therapeutic agents for breast cancer and their role in immuno-oncology.

Expert Rev Anticancer Ther 2019 Jul 20;19(7):569-587. Epub 2019 Jun 20.

a Pennsylvania Cancer and Regenerative Medicine Research Center , Baruch S. Blumberg Institute, Pennsylvania Biotechnology Center , Wynnewood , PA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2019.1615889DOI Listing
July 2019

A novel small-molecule antagonizes PRMT5-mediated KLF4 methylation for targeted therapy.

EBioMedicine 2019 Jun 14;44:98-111. Epub 2019 May 14.

Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, United States; Department of Pharmacology, Northwestern University Feinberg School of Medicine, United States; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, United States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523964193031
Publisher Site
http://dx.doi.org/10.1016/j.ebiom.2019.05.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604046PMC
June 2019

Emerging Role of Genomics and Cell-Free DNA in Breast Cancer.

Curr Treat Options Oncol 2019 Jun 29;20(8):68. Epub 2019 Jun 29.

Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, 710 N Fairbanks Court, Suite 8-250A, Chicago, IL, 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-019-0667-9DOI Listing
June 2019

Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?

Cancer Treat Rev 2019 Feb 11;73:73-83. Epub 2019 Jan 11.

Department of Medicine (DAME), University of Udine, Italy; Department of Medical Oncology, Centro di Riferimento Oncologico (CRO), IRCCS, Aviano, PN, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03057372193000
Publisher Site
http://dx.doi.org/10.1016/j.ctrv.2019.01.004DOI Listing
February 2019

Palbociclib and Fulvestrant in Breast Cancer. Reply.

N Engl J Med 2019 Feb;380(8):797

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1816595DOI Listing
February 2019

Impeding Circulating Tumor Cell Reseeding Decelerates Metastatic Progression and Potentiates Chemotherapy.

Mol Cancer Res 2018 12 16;16(12):1844-1854. Epub 2018 Aug 16.

Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-18-0302DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279516PMC
December 2018

Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer.

N Engl J Med 2018 Nov 20;379(20):1926-1936. Epub 2018 Oct 20.

From the Institute of Cancer Research and Royal Marsden Hospital, London (N.C.T.); David Geffen School of Medicine at University of California, Los Angeles, Santa Monica (D.J.S.), and Pfizer Oncology, San Diego (X.H.) - both in California; National Cancer Center, Goyang-si, Gyeonggi-do (J.R.), and Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul (S.-A.I.) - both in South Korea; Dnipropetrovsk Medical Academy, City Multiple-Discipline Clinical Hospital 4, Dnipropetrovsk, Ukraine (I.B.); National Hospital Organization Osaka National Hospital, Osaka (N.M.), and Aichi Cancer Center Hospital, Nagoya (H.I.) - both in Japan; Istituto Europeo di Oncologia (M. Colleoni) and Pfizer Oncology (C.G.) - both in Milan; Abramson Cancer Center, University of Pennsylvania, Philadelphia (A.D.), and Pfizer Oncology, Collegeville (C.H.B.) - both in Pennsylvania; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S. Loi); Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada (S.V.); Brustzentrum der Universität München, Munich (N.H.), and the German Breast Group, Neu-Isenburg (S. Loibl) - both in Germany; Institut Gustave Roussy, Villejuif, France (F.A.); Pfizer Oncology, Cambridge, MA (K.P.T.); and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago (M. Cristofanilli).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1810527
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1810527DOI Listing
November 2018

Regarding the Congruence Between 2 Circulating Tumor DNA Sequencing Assays.

JAMA Oncol 2018 Oct;4(10):1430

International Society of Liquid Biopsy, Granada, Spain.

View Article

Download full-text PDF

Source
http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jam
Publisher Site
http://dx.doi.org/10.1001/jamaoncol.2018.2320DOI Listing
October 2018

NQO1 regulates mitotic progression and response to mitotic stress through modulating SIRT2 activity.

Free Radic Biol Med 2018 10 13;126:358-371. Epub 2018 Aug 13.

Laboratory for Molecular Cancer Biology, Department of Radiation Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.freeradbiomed.2018.08.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170003PMC
October 2018

Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing.

J Clin Oncol 2018 Oct 19:JCO1800328. Epub 2018 Oct 19.

Thomas P. Slavin, Kar Wing Kevin Tsang, Susan L. Neuhausen, Stacy W. Gray, and Jeffrey N. Weitzel, City of Hope, Duarte; Kimberly C. Banks, Darya Chudova, Justin I. Odegaard, Rebecca J. Nagy, Christine E. Lee, and Richard B. Lanman, Guardant Health, Redwood City; Razelle Kurzrock, University of California, San Diego, Moores Cancer Center, San Diego, CA; Geoffrey R. Oxnard, Dana-Farber Cancer Institute; Aditya Bardia, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA; Massimo Cristofanilli, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Angel A. Rodriguez, Houston Methodist Hospital; Funda Meric-Bernstam, The University of Texas MD Anderson Cancer Center, Houston, TX; Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Mike F. Janicek, Arizona Oncology Associates Gynecology Oncology, Scottsdale, AZ; Michael Lilly, Medical University of South Carolina, Charleston, SC; and Guru Sonpavde, The University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.18.00328
Publisher Site
http://dx.doi.org/10.1200/JCO.18.00328DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286162PMC
October 2018

Phase I study of alpelisib (BYL-719) and trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer (MBC) after trastuzumab and taxane therapy.

Breast Cancer Res Treat 2018 Sep 30;171(2):371-381. Epub 2018 May 30.

Lynn Sage Breast Cancer Program, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, 676 N St. Clair St. Suite 850, Chicago, IL, 60611, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-018-4792-0
Publisher Site
http://dx.doi.org/10.1007/s10549-018-4792-0DOI Listing
September 2018

From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing.

Value Health 2018 09 3;21(9):1062-1068. Epub 2018 Aug 3.

Department of Clinical Pharmacy, UCSF Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), University of California San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10983015183226
Publisher Site
http://dx.doi.org/10.1016/j.jval.2018.06.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374027PMC
September 2018

Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancer.

Hum Pathol 2018 07 22;77:121-129. Epub 2018 Apr 22.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2018.04.002DOI Listing
July 2018

Emerging Innovative Therapeutic Approaches Leveraging Cyclin-Dependent Kinase Inhibitors to Treat Advanced Breast Cancer.

Clin Pharmacol Ther 2018 06 30;103(6):1009-1019. Epub 2018 Jan 30.

Department of Medicine-Hematology and Oncology, Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpt.965DOI Listing
June 2018

Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer.

Clin Cancer Res 2018 02 27;24(3):560-568. Epub 2017 Nov 27.

Department of Medicine-Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-2092DOI Listing
February 2018

Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize.

Cancer Res 2018 02 2;78(4):845-852. Epub 2018 Feb 2.

Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-17-2748DOI Listing
February 2018

Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors: A meta-regression of randomised prospective studies.

Eur J Cancer 2017 11 19;86:257-265. Epub 2017 Oct 19.

Department of Medical, Surgery and Health Sciences, University of Trieste, Piazza Ospitale 1, 34129 Trieste, Italy; Breast Cancer Unit and Translational Research Unit, ASST Cremona, Viale Concordia 1, 26100 Cremona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.09.018DOI Listing
November 2017

Detection of Activating Estrogen Receptor Gene () Mutations in Single Circulating Tumor Cells.

Clin Cancer Res 2017 Oct 5;23(20):6086-6093. Epub 2017 Jul 5.

Department of Cancer Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-1173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641250PMC
October 2017

Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer.

Breast Cancer Res Treat 2017 Oct 7;165(3):733-741. Epub 2017 Jul 7.

Department of Medicine-Hematology and Oncology, Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-017-4372-8
Publisher Site
http://dx.doi.org/10.1007/s10549-017-4372-8DOI Listing
October 2017

Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Circulating Tumor DNA in Breast Cancer.

Mol Cancer Ther 2017 07 26;16(7):1412-1420. Epub 2017 Apr 26.

Developmental Therapeutics Program of Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-17-0061DOI Listing
July 2017

Developmental therapeutics for inflammatory breast cancer: Biology and translational directions.

Oncotarget 2017 Feb;8(7):12417-12432

Developmental Therapeutics Program, Division of Hematology/Oncology, Feinberg School of Medicine, Chicago, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.13778DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355355PMC
February 2017

Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug development.

Cancer Treat Rev 2017 Feb 5;53:111-119. Epub 2017 Jan 5.

Developmental Therapeutics Program, Division of Hematology/Oncology, Feinberg School of Medicine, Chicago, USA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2016.12.010DOI Listing
February 2017

Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.

Breast Cancer Res Treat 2017 01 22;161(1):83-94. Epub 2016 Oct 22.

Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-4026-2DOI Listing
January 2017

The Growing Role of CDK4/6 Inhibitors in Treating Hormone Receptor-Positive Advanced Breast Cancer.

Curr Treat Options Oncol 2017 01;18(1)

Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, 710 North Fairbanks Ct, Suite 8-250a, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-017-0443-7DOI Listing
January 2017

Metastatic breast cancer: focus on endocrine sensitivity.

Lancet 2016 12 29;388(10063):2961-2962. Epub 2016 Nov 29.

Department of Medicine, Division of Hematology and Oncology, Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(16)32418-7DOI Listing
December 2016

Breast Cancer Stem Cell Isolation.

Methods Mol Biol 2016 ;1406:121-35

Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Bluemle Life Sciences Building, 233 South 10th Street, Philadelphia, PA, 19107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-3444-7_10DOI Listing
October 2016

GSK-3 inhibition overcomes chemoresistance in human breast cancer.

Cancer Lett 2016 10 14;380(2):384-92. Epub 2016 Jul 14.

Center for Developmental Therapeutics, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 2170 Campus Drive, Evanston, IL 60208, USA; Chemistry of Life Processes Institute, Northwestern University, 2170 Campus Drive, Evanston, IL, 60208, USA; Northwestern Medicine Developmental Therapeutics Institute, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Olson Pavilion, 233 East Superior Street, Chicago, IL 60611, USA; Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Searle Building 8-510, 320 East Superior Street, Chicago, IL 60611, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2016.07.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786372PMC
October 2016

Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer.

J Clin Oncol 2016 09 6;34(25):2961-8. Epub 2016 Jun 6.

Charlotte Fribbens, Ben O'Leary, Sarah Hrebien, Isaac Garcia-Murillas, Matthew Beaney, Mitch Dowsett, and Nicholas C. Turner, Institute of Cancer Research; Charlotte Fribbens, Ben O'Leary, Stephen R.D. Johnston, and Nicholas C. Turner, Royal Marsden Hospital; Lucy Kilburn and Judith M. Bliss, The Institute of Cancer Research Clinical Trials and Statistics Unit, London, UK; Massimo Cristofanilli, Thomas Jefferson University, Philadelphia, PA; Fabrice Andre, Institut Gustave Roussy, Villejuif, France; Sherene Loi, University of Melbourne, Melbourne, Australia; Sibylle Loibl, German Breast Group, Neu-Isenburg, Germany; and John Jiang, Cynthia Huang Bartlett, and Maria Koehler, Pfizer, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.3061DOI Listing
September 2016

Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.

Int J Mol Sci 2016 Sep 30;17(10). Epub 2016 Sep 30.

Department of Medicine-Hematology and Oncology, Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms17101665DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085698PMC
September 2016

Prospective changes in global DNA methylation and cancer incidence and mortality.

Br J Cancer 2016 08 28;115(4):465-72. Epub 2016 Jun 28.

Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, 680 N. Lake Shore Drive, Suite 1400, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2016.205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985350PMC
August 2016

Genomic and Immunological Tumor Profiling Identifies Targetable Pathways and Extensive CD8+/PDL1+ Immune Infiltration in Inflammatory Breast Cancer Tumors.

Mol Cancer Ther 2016 07 19;15(7):1746-56. Epub 2016 Apr 19.

Translational R&D Oncology Group, Quintiles, Westmont, Illinois. Department of Pharmacology, University of Illinois at Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0353DOI Listing
July 2016

Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients.

BMC Cancer 2016 07 25;16:526. Epub 2016 Jul 25.

Translational Medicine Center, Laboratory of Oncology, Affiliated Hospital of Academy of Military Medical Sciences, 8 Dongdajie, Beijing, 100071, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-016-2578-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960713PMC
July 2016

Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells.

PLoS One 2015 24;10(7):e0132710. Epub 2015 Jul 24.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; The University of Texas Graduate School of Biomedical Sciences at Houston, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0132710PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514595PMC
May 2016

Inflammatory breast cancer: a new approach.

Lancet Oncol 2016 05 28;17(5):544-6. Epub 2016 Mar 28.

Robert Lurie Cancer Center, Northwestern University, Chicago, IL 60611, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)00064-4DOI Listing
May 2016

Is Personalized Medicine Here?

Oncology (Williston Park) 2016 Apr;30(4):293-303, 307

View Article

Download full-text PDF

Source
April 2016

Using circulating tumor cells to guide therapy in breast cancer: could this replace biopsies?

Pharmacogenomics 2015 7;16(7):669-72. Epub 2015 May 7.

Department of Medical Oncology, Thomas Jefferson University, 1025 Walnut St, Suite 700, Philadelphia, PA 19107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.15.36DOI Listing
March 2016

Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.

Breast Cancer Res Treat 2015 Dec 16;154(3):563-71. Epub 2015 Nov 16.

Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-015-3636-4DOI Listing
December 2015

Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells.

EBioMedicine 2015 Nov 18;2(11):1821-6. Epub 2015 Sep 18.

Department of Medical Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2015.09.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740300PMC
November 2015

A Preclinical Model of Inflammatory Breast Cancer to Study the Involvement of CXCR4 and ACKR3 in the Metastatic Process.

Transl Oncol 2015 Oct;8(5):358-67

Department of Pharmacology and Physiology, Drexel University College of Medicine, 245 N. 15th Street, Philadelphia, PA 19102; Department of Microbiology and Immunology, Drexel University College of Medicine, 245 N. 15th Street, Philadelphia, PA 19102. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2015.07.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631055PMC
October 2015

The effects of erythropoiesis-stimulating agents on the short-term and long-term survivals in metastatic breast cancer patients receiving chemotherapy: a SEER population-based study.

Breast Cancer Res Treat 2015 Sep 12;153(2):407-16. Epub 2015 Aug 12.

Division of Population Science, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10549-015-3532
Web Search
http://link.springer.com/10.1007/s10549-015-3532-y
Publisher Site
http://dx.doi.org/10.1007/s10549-015-3532-yDOI Listing
September 2015

Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

J Clin Oncol 2015 Aug 20;33(24):2695-704. Epub 2015 Jul 20.

Catherine Van Poznak and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Robert C. Bast, Ana M. Gonzalez-Angulo, and William F. Symmans, University of Texas MD Anderson Cancer Center, Houston; Robert G. Mennel, Texas Oncology, Dallas, TX; Massimo Cristofanilli, Thomas Jefferson University-Kimmel Cancer Center, Philadelphia, PA; Matthew P. Goetz and Minetta C. Liu, Mayo Clinic, Rochester, MN; David G. Hicks, University of Rochester Medical Center, Rochester, NY; Elizabeth G. Hill, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC; Wanda Lucas, Georgetown University, Washington, DC; Ingrid A. Mayer, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN; and Lyndsay N. Harris, Seidman Cancer Center, Case Western Reserve University, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.1459DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478102PMC
August 2015

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Authors:
Ayalew Tefferi Hagop Kantarjian S Vincent Rajkumar Lawrence H Baker Jan L Abkowitz John W Adamson Ranjana Hira Advani James Allison Karen H Antman Robert C Bast John M Bennett Edward J Benz Nancy Berliner Joseph Bertino Ravi Bhatia Smita Bhatia Deepa Bhojwani Charles D Blanke Clara D Bloomfield Linda Bosserman Hal E Broxmeyer John C Byrd Fernando Cabanillas George Peter Canellos Bruce A Chabner Asher Chanan-Khan Bruce Cheson Bayard Clarkson Susan L Cohn Gerardo Colon-Otero Jorge Cortes Steven Coutre Massimo Cristofanilli Walter J Curran George Q Daley Daniel J DeAngelo H Joachim Deeg Lawrence H Einhorn Harry P Erba Francisco J Esteva Elihu Estey Isaiah J Fidler James Foran Stephen Forman Emil Freireich Charles Fuchs James N George Morie A Gertz Sergio Giralt Harvey Golomb Peter Greenberg Jordan Gutterman Robert I Handin Samuel Hellman Paulo Marcelo Hoff Ronald Hoffman Waun Ki Hong Mary Horowitz Gabriel N Hortobagyi Clifford Hudis Jean Pierre Issa Bruce Evan Johnson Philip W Kantoff Kenneth Kaushansky David Khayat Fadlo R Khuri Thomas J Kipps Margaret Kripke Robert A Kyle Richard A Larson Theodore S Lawrence Ross Levine Michael P Link Scott M Lippman Sagar Lonial Gary H Lyman Maurie Markman John Mendelsohn Neal J Meropol Yoav Messinger Therese M Mulvey Susan O'Brien Roman Perez-Soler Raphael Pollock Josef Prchal Oliver Press Jerald Radich Kanti Rai Saul A Rosenberg Jacob M Rowe Hope Rugo Carolyn D Runowicz Brenda M Sandmaier Alan Saven Andrew I Schafer Charles Schiffer Mikkael A Sekeres Richard T Silver Lillian L Siu David P Steensma F Marc Stewart Wendy Stock Richard Stone Rainer Storb Louise C Strong Martin S Tallman Michael Thompson Naoto T Ueno Richard A Van Etten Julie M Vose Peter H Wiernik Eric P Winer Anas Younes Andrew D Zelenetz Charles A LeMaistre

Mayo Clin Proc 2015 Aug 23;90(8):996-1000. Epub 2015 Jul 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2015.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365030PMC
August 2015

Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer.

N Engl J Med 2015 Jul 1;373(3):209-19. Epub 2015 Jun 1.

From Royal Marsden Hospital, London (N.C.T.); National Cancer Center, Goyang-si, South Korea (J.R.); Institut Gustave Roussy, Villejuif, France (F.A.); Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S. Loi); Sunnybrook Odette Cancer Centre, Toronto (S.V.); Aichi Cancer Center Hospital, Nagoya, Japan (H.I.); Brustzentrum der Universität München, Munich (N.H.), and German Breast Group Forschungs, Neu-Isenburg (S. Loibl) - both in Germany; Pfizer, New York (C.H.B., M.K.), La Jolla, CA (K.Z., S.R.), and Milan (C.G.); and Thomas Jefferson University, Philadelphia (M.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1505270DOI Listing
July 2015

Neoadjuvant Model in Cancer Treatment: From Clinical Opportunity to Health-Care Utility.

J Natl Cancer Inst Monogr 2015 May;2015(51):1-3

U.O. Multidisciplinare di Patologia Mammaria, U.S Terapia Molecolare e Farmacogenomica (DG, AB), Direzione Sanitaria (CR), A.O. Istituti Ospitalieri di Cremona, Cremona, Italy (DG, AB); Department of Anatomical Pathology, Peter MacCallum Cancer Centre, East Melbourne, Australia (SBF); Thomas Jefferson University Hospital, Philadelphia, PA (MC); San Raffaele - Scientific Institute, Milan, Italy (GB); Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy (AZ); Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT (CH); Division of Pathology, European Institute of Oncology, Milan, Italy (MB); Department of Policy Analysis and Public Management, Research Center on Health and Social Care Management, CERGAS, SDA Bocconi School of Management, Bocconi University, Milan, Italy (RT); Health Technology Assessment - Regione Lombardia, Italy (MT).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgv022DOI Listing
May 2015

IBC as a Rapidly Spreading Systemic Disease: Clinical and Targeted Approaches Using the Neoadjuvant Model.

J Natl Cancer Inst Monogr 2015 May;2015(51):56-9

Department of Medical Oncology, Dubai Hospital, United Arab Emirates (SD); Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA (MC).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgv017DOI Listing
May 2015

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013).

J Natl Cancer Inst Monogr 2015 May;2015(51):90-6

Medical Oncology Unit (VA, ABe), University of Brescia, and Breast Unit (RP, LV, ELS) Spedali Civili Hospital, Brescia, Italy; U.O. Multidisciplinare di Patologia Mammaria, S.S. Terapia Molecolare e Farmacogenomica, AZ. Istituti Ospitalieri di Cremona, Cremona, Italy (DG, AR, MRC, LD, ABo); Departments of Radiation Oncology (TB) and Pathology (FS), University of Texas MD Anderson Cancer Center, Houston, TX; Department of Medical Oncology and Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA (MC); Division of Experimental Therapeutics, Breast Cancer Program, Istituto Europeo di Oncologia, Milan, Italy (GC); Biomarkers Unit, Department of Experimental Oncology and Molecular Medicine (MGD), and Medical Oncology Unit (SDC), Fondazione IRCCS - Istituto Nazionale Tumori, Milan, Italy (MGD); Academic Department of Biochemistry, Biochemical Endocrinology (MD), Department of Surgery, Breast Unit (PB), and The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research and Breast Unit (MD, GS), Royal Marsden Hospital, London, UK; Department of Pathology, Melbourne University, Parkville, Australia (SF); Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK (ALH); Mount Vernon Cancer Centre, London, UK (AM); Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT (CH); Memorial Sloan Kettering Cancer Center, New York, NY (CAH); Division of Medical Oncology, Department of Hemato-oncology, IRCCS Policlinico 'San Matteo' Foundation, Pavia, Italy (PP); Dipartimento Medicina di Laboratorio, SC Anatomia ed Istocitopatologia Diagnostica e di Screening, A.O.U. Città della Salute e della Scienza di Torino, Università di Torino, Turin, Italy (AS); N. N. Petrov Research Institute of Oncology, St. Petersburg, Russia (VS); German Breast Group & University of Frankfurt, Neu-Isenburg, Germany (GvM); The Russell H. Morgan Department of Radiology

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgv023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009414PMC
May 2015

Molecular characterization and targeted therapeutic approaches in breast cancer.

Breast Cancer Res 2015 Apr 23;17:60. Epub 2015 Apr 23.

Department of Medical Oncology, Jefferson University Hospital, 1100 Walnut Street, Philadelphia, PA, 19107, USA.

View Article

Download full-text PDF

Source
http://breast-cancer-research.biomedcentral.com/articles/10.
Publisher Site
http://dx.doi.org/10.1186/s13058-015-0560-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407294PMC
April 2015